we live in the future – the next step is designing large gene insertions and fine scale editing with AI @ProfluentBio “One dose of VERVE-102 (in vivo base editor) led to dose-dependent, substantial, and sustained reductions in PCSK9 and LDL cholesterol levels.”
@nathanbenaich
-
Revenue ramp via costly tokenizer in 4.7 boosts tokens per query
By
–
i think ppl forget that rev ramp might also be driven by a more spenny tokenizer on 4.7 up to 1.3x more tokens for the same query revmaxxing by tokenizer upgrade (amongst other things ofc)
-
New “Deep Learning Math Workbook” by Prof. Tom Yeh
By
–
next week's @airstreet nyc ai meetup roster: – researchers from Cursor, Google DeepMind, Microsoft Research, Meta Superintelligence Labs, Reflection AI, Apple, Runway, AssemblyAI, fal, Databricks, Scale.
– founders at edra, lumaril, sybil, genesis, coefficient
– speakers from -
Guide to Design, Build, and Scale Goal-Driven, LLM-Powered Agents
By
–
the science of scaling – at @raais 2026, @ted_moskovitz and i will have a fireside chat on what it takes to build and scale frontier ai at @anthropicai this'll be fascinating come join!
-
Startup Acquisition Price vs Investment Commitment: Key Difference
By
–
guys – a company committing to invest up to $1b in a new initiative as a result of buying a startup is not the same thing as that startup being bought for $1b
-
State of AI Newsletter Latest Issue Now Live
By
–
latest issue of state of ai newsletter, on @airstreetpress is live – check it out 🙂
-
10th Annual RAAIS AI Conference Coming to London
By
–
little over a month til our 10th annual @raais in london ft talent from the best and brightest in ai from big labs, startups, and academia been at this for a while 🙂
-
Poolside Launches Open Weight Models and Platform
By
–
more @airstreet news! poolside have dropped their first set of open weight models and platform! more frontier ai for more ppl!
-
Profluent and Eli Lilly Partner on AI-Designed Gene Editors
By
–
Today, @ProfluentBio and @EliLillyandCo announce a multi-$B partnership to use our AI models to design custom recombinases, a new class of gene editor capable of large-scale DNA editing across multiple diseases. I'm so proud of the team – Profluent is an n=1 company.
-
Sereoract AI Secures $110M Series B Funding Round
By
–
after today’s tasty $110m series b for @sereactai
, we’re proud to bring you more banger news from @airstreet companies tmrw 🙂